Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCT

NCT06061094 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

220

Enrollment

OTHER

Sponsor class

Conditions

Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Interventions

DRUG: Imatinib
DRUG: Ponatinib
DRUG: Blinatumomab
OTHER: Indication for stem cell transplantation

Sponsor

Goethe University

Collaborators

[object Object]
[object Object]